API 0.74% $1.35 australian pharmaceutical industries limited

api - thoughts

  1. 171 Posts.
    lightbulb Created with Sketch. 8
    There seems to be some focus on API losing out big time
    to supermarkets,etc, yet whenever I look I usually see a
    basically empty isle, particularly @ Woolies. Apart from small incidental items I see so far, little take-up.

    Chemist W/house spends large on advertising ,surely this
    coupled with selling heavily discounted lines , and paying
    top level rents all dilute profits greatly ? .Their stores
    only seem to work surrounded by other chemists that do much "complimentary " sales to the public .
    If C/Warehouse has been given initial generous terms from Sigma,how will they perform as/when this is wound back?

    The 52$ million in loans to Pharmacy customers has been
    around for a long time,and is now factored in more critically ,because of changed accounting ,that treats loans and guarantees as possible total losses, which of
    course is true in all such situations.

    The 42$ million store modelling asset charge' seems to be
    the reduction on the amountof value that was projected .

    NPAT up 29 % + Priceline sales growth of 5.3% seem to of
    been overloked a tad . imho ..


 
watchlist Created with Sketch. Add API (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.